IBEX CEO sells 12,000 shares around $29–30

IBEX Ltd Chief Executive Officer Robert Thomas Dechant reported selling a total of 12,000 Common Shares in two open-market transactions.

Rhea-AI Filing Summary

IBEX Ltd Chief Executive Officer Robert Thomas Dechant reported selling a total of 12,000 Common Shares in two open-market transactions. He sold 6,000 shares on February 19, 2026 at a weighted average price of $29.7264 per share and another 6,000 shares on February 20, 2026 at a weighted average price of $29.3997 per share. After these sales, he continued to hold 281,406 Common Shares directly.

Insider Trade Summary

Net Seller: 12,000 shares

Net Sell 2 txns

Insider Dechant Robert Thomas

Role Chief Executive Officer

Sold 12,000 shs ($355K)

Type	Security	Shares	Price	Value
Sale	Common Shares	6,000	$29.3997	$176K
Sale	Common Shares	6,000	$29.7264	$178K

Holdings After Transaction: Common Shares — 281,406 shares (Direct)

Footnotes (2)

1. F1. This transaction was executed in multiple trades at prices ranging from $29.47 to $29.97; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
2. F2. This transaction was executed in multiple trades at prices ranging from $29.02 to $29.87; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IBEX (IBEX) report in this Form 4?

IBEX reported that CEO Robert Thomas Dechant sold 12,000 Common Shares in total. The transactions were executed as open-market sales over two days at weighted average prices around $29 to $30 per share.

How many IBEX (IBEX) shares did the CEO sell and at what prices?

The CEO sold 6,000 IBEX Common Shares on February 19, 2026 at a weighted average price of $29.7264 and 6,000 shares on February 20, 2026 at a weighted average price of $29.3997, totaling 12,000 shares sold.

How many IBEX (IBEX) shares does the CEO hold after these sales?

After the reported open-market sales, CEO Robert Thomas Dechant directly holds 281,406 IBEX Common Shares. This figure reflects his ownership following the 12,000 shares sold across the two disclosed transactions.

Were the IBEX (IBEX) CEO’s share sales done in multiple trades?

Yes. Each day’s transaction was executed in multiple trades within a price range. The reported prices are weighted averages, and the CEO has undertaken to provide detailed trade-level information upon request to the issuer, shareholders, or the SEC staff.

What type of transactions were reported for IBEX (IBEX) in this filing?

The filing shows non-derivative open-market sales of IBEX Common Shares coded as “S.” These represent standard stock sales rather than option exercises or derivative-related activity, and they reduced the CEO’s direct holdings by 12,000 shares in total.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 04:23 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dechant Robert Thomas

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	02/19/2026		S		6,000	D	$29.7264(1)	287,406	D
Common Shares	02/20/2026		S		6,000	D	$29.3997(2)	281,406	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $29.47 to $29.97; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

2. This transaction was executed in multiple trades at prices ranging from $29.02 to $29.87; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.